Iressa 250 MG Oral Tablet
- RxCUI
- 402091
- RxNorm name
- Iressa 250 MG Oral Tablet
- Display name
- Iressa 250 MG Oral Tablet
- Full name
- Iressa 250 MG Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| IRESSA | GEFITINIB | AstraZeneca Pharmaceuticals LP | 827d60e8-7e07-41b7-c28b-49ef1c4a5a41 | 2023-02-28 | Warnings, Adverse reactions | 402091 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 827d60e8-7e07-41b7-c28b-49ef1c4a5a41 | Iressa 250 MG Oral Tablet | SY | 19 | These highlights do not include all the information needed to use IRESSA ® safely and effectively. See full prescribing information for IRESSA. IRESSA (gefitinib) tablets for oral use Initial U.S. Approval: 2015 | 20230228 |
| 827d60e8-7e07-41b7-c28b-49ef1c4a5a41 | Iressa 250 MG Oral Tablet | PSN | 19 | These highlights do not include all the information needed to use IRESSA ® safely and effectively. See full prescribing information for IRESSA. IRESSA (gefitinib) tablets for oral use Initial U.S. Approval: 2015 | 20230228 |
| 827d60e8-7e07-41b7-c28b-49ef1c4a5a41 | gefitinib 250 MG Oral Tablet [Iressa] | SBD | 19 | These highlights do not include all the information needed to use IRESSA ® safely and effectively. See full prescribing information for IRESSA. IRESSA (gefitinib) tablets for oral use Initial U.S. Approval: 2015 | 20230228 |